Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia-Reference-Cited by-同舟云学术

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

Published:2023-04 Issue:4 Volume:18 Page:436-446
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Mitsudomi Tetsuya,Tan Daniel,Yang James Chih-Hsin,Ahn Myung-Ju,Batra Ullas,Cho Byoung-Chul,Cornelio Gerardo,Lim Tony,Mok Tony,Prabhash Kumar,Reungwetwattana Thanyanan,Ren Sheng-Xiang,Singh Navneet,Toyooka Shinichi,Wu Yi-Long,Yang Pan-Chyr,Yatabe Yasushi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference49 articles.

1. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview [e-pub ahead of print]. Int J Cancer. https://doi.org/10.1002/ijc.33588, accessed November 2, 2021.

2. The Economist Intelligence Unit Limited. Cancer preparedness in Asia-Pacific. https://worldcancerinitiative.economist.com/pdf/Roche-cancer-preparedness-in-asia/Roche_Cancer_White_paper.pdf. Accessed November 2, 2021.

3. Global patterns and trends in lung cancer incidence: A population-based study;Zhang;J Thorac Oncol,2021

4. East Meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians;Zhou;Chin J Cancer,2011

5. Risk factors for primary lung cancer among never smokers by gender in a matched case–control study;Lo;Cancer Causes Control,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review;The Journal of Liquid Biopsy;2024-09

2. Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine;Pathology;2024-08

3. Identification and treatment of lung cancer oncogenic drivers in a diverse safety net setting;Clinical Lung Cancer;2024-08

4. Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer;JAMA Oncology;2024-07-01

5. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27